Pediatric Hematologist, Global Clinical Program Director R&DCSL BehringKing of Prussia, Pennsylvania, United States
PB0541 - IX-TEND: A Phase IV Observational, Long-term Follow-up Study on the Safety and Efficacy of Etranacogene Dezaparvovec in Patients with Hemophilia B
Monday, June 24, 202413:45 – 14:45 ICT
